Related Experiment Video
Updated: Aug 5, 2025

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
COVID-19 and Vasa vasorum: New Atherogenic Factor? A Case Report and Autopsy Findings
Julia A Macarova1, Sofia A Malakhova1, Tatiana A Novitskaya1,2
1Laboratory of the Microangiopathic Mechanisms of Atherogenesis, Saint Petersburg State University, 199034 Saint-Petersburg, Russia.
Insights
COVID-19 patients face increased cardiovascular risks, potentially due to SARS-CoV-2 affecting blood vessels. This study links viral infection to atherosclerosis and stroke via Vasa vasorum inflammation.
Area of Science:
- Cardiovascular Pathology
- Infectious Disease
- Vascular Biology
Background:
- COVID-19 is associated with elevated cardiovascular complications, including thrombosis and thromboembolism.
- The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) may destabilize atherosclerotic plaques.
- Viral infection can progressively alter blood vessels, impacting cardiovascular health.
Observation:
- A fatal case of ischemic brain disease is presented, stemming from cerebral atherosclerosis and a stroke during COVID-19 infection.
- Autopsy revealed perivascular lymphocytic infiltration and vasculitis of the Vasa vasorum.
- Thrombi were observed in the adventitial microvasculature of the Vasa vasorum.
Findings:
- SARS-CoV-2 infection can induce inflammation and vasculitis in the Vasa vasorum.
- This inflammation contributes to the destabilization of atherosclerotic plaques.
- Vasa vasorum vasculitis is implicated as a mechanism for cardiovascular complications in COVID-19 patients.
Implications:
- The Vasa vasorum plays a critical role in atherogenesis and its exacerbation during viral infections.
- Understanding this mechanism may lead to targeted therapies for cardiovascular complications in COVID-19.
- This research highlights the intricate relationship between viral infections and pre-existing cardiovascular conditions.
Abstract:
Patients with COVID-19 demonstrate higher rates of cardiovascular complications, including thromboses and thromboembolism. One may suppose that the action of SARS-CoV-2 transforms stable atherosclerotic plaques into unstable status. Cardiovascular complications in COVID-19 may be caused by progressive viral alteration of the blood vessels, including Vasa vasorum. A lethal case of ischemic brain disease caused by cerebral atherosclerosis and exacerbated by a stroke during COVID-19 infection is briefly described. The results of the autopsy showed perivascular lymphocytic infiltration and signs of Vasa vasorum vasculitis with thrombi of adventitial microvasculature. The data discussed in the article are interpreted in the context of the concept giving the important role in atherogenesis to Vasa vasorum.
More Related Videos
08:43Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
11:00A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium
Published on: June 22, 2010
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...